Rating History for Alder Biopharm (ALDR) by UBS

More Stocks Rated by UBS | Latest Ratings for ALDR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/17/2019 Andrew Ang Upgrade Neutral
(Sell)		 19.50
(9.00)		 10.06
(18.88)		 87.67% Details